Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Primary neuroendocrine neoplasms of the breast: still open issues
M Gallo, S Campione, V Di Vito, N Fortunati… - Frontiers in …, 2021 - frontiersin.org
Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less
than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going …
than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going …
The classification of neuroendocrine neoplasms of the breast and its clinical relevance
S Uccella - Virchows Archiv, 2022 - Springer
Neuroendocrine neoplasms of the breast (Br-NENs) are rare tumors of the mammary gland.
Their definition and classification have been a matter of discussion for more than half a …
Their definition and classification have been a matter of discussion for more than half a …
[HTML][HTML] Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast
GR Bean, S Najjar, SJ Shin, EM Hosfield… - Modern Pathology, 2022 - Elsevier
Neuroendocrine carcinomas (NEC) of the breast are exceedingly rare tumors, which are
classified in the WHO system as small cell (SCNEC) and large cell (LCNEC) carcinoma …
classified in the WHO system as small cell (SCNEC) and large cell (LCNEC) carcinoma …
HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor
N Krawczyk, M Banys, H Neubauer… - Anticancer …, 2009 - ar.iiarjournals.org
Background: Persistence of disseminated tumor cells (DTCs) is observed in 10 to 15% of
breast cancer patients and is associated with poor prognosis. These patients might benefit …
breast cancer patients and is associated with poor prognosis. These patients might benefit …
Invasive breast carcinoma with neuroendocrine differentiation: a single-center analysis of clinical features and prognosis
N Krawczyk, R Röwer, M Anlauf… - Geburtshilfe und …, 2022 - thieme-connect.com
Introduction Invasive breast cancer with neuroendocrine differentiation is a rare subtype of
breast malignancy. Due to frequent changes in the definition of these lesions, the correct …
breast malignancy. Due to frequent changes in the definition of these lesions, the correct …
Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center's experience of a heterogenous entity
M Püsküllüoğlu, A Grela-Wojewoda… - Frontiers in …, 2024 - frontiersin.org
Background Primary neuroendocrine neoplasms of the breast (Br-NENs) are rare. The
classification has been updated in recent years making interpretation of the data published …
classification has been updated in recent years making interpretation of the data published …
Primary breast neuroendocrine tumors: an analysis of the national cancer database
EO Martinez, JM Jorns, AL Kong, J Kijak… - Annals of surgical …, 2022 - Springer
Background Primary breast neuroendocrine tumors (BNETs) represent< 1% of breast
cancers. Diagnosing BNETs can be challenging, and a limited amount of cohort data …
cancers. Diagnosing BNETs can be challenging, and a limited amount of cohort data …
Head to head: do neuroendocrine tumours in the breast truly exist?
E Rakha, PH Tan - Histopathology, 2022 - Wiley Online Library
Breast cancer (BC) is a heterogeneous disease with a spectrum of morphological features.
Concepts of histogenesis and differentiation in BC remain controversial. Recent evidence …
Concepts of histogenesis and differentiation in BC remain controversial. Recent evidence …
Clinical characteristics and survival of extrapulmonary small cell carcinoma in 11 different primary tumor sites in the United States, 1975–2016
JL Xu, Y Guo - Current Medical Research and Opinion, 2021 - Taylor & Francis
Objective Few studies have investigated extrapulmonary small cell carcinoma (EPSCC) in a
systematic way. This study is to analyze EPSCC in 11 tumor sites from different aspects in …
systematic way. This study is to analyze EPSCC in 11 tumor sites from different aspects in …
Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation
OA Sagan, A Rothstein, B Jambunathan… - Frontiers in …, 2023 - frontiersin.org
Background The epidermal growth factor receptor (EGFR) p. Thr790Met (T790M) mutation
was discovered as a resistance mechanism in patients with lung cancer treated with first-and …
was discovered as a resistance mechanism in patients with lung cancer treated with first-and …